Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration.

Liu G, Gong Y, Zhang R, Piao L, Li X, Liu Q, Yan S, Shen Y, Guo S, Zhu M, Yin H, Funk CD, Zhang J, Yu Y.

FASEB J. 2018 Oct;32(10):5413-5425. doi: 10.1096/fj.201800173R. Epub 2018 May 3.

PMID:
29723062
2.

Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury.

Kohno T, Urao N, Ashino T, Sudhahar V, McKinney RD, Hamakubo T, Iwanari H, Ushio-Fukai M, Fukai T.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):805-13. doi: 10.1161/ATVBAHA.112.300862. Epub 2013 Jan 24.

3.

Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.

He YH, Wang XQ, Zhang J, Liu ZH, Pan WQ, Shen Y, Zhu ZB, Wang LJ, Yan XX, Yang K, Zhang RY, Shen WF, Ding FH, Lu L.

Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):717-729. doi: 10.1161/ATVBAHA.116.308210. Epub 2017 Feb 9.

PMID:
28183701
4.

D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.

Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS.

FASEB J. 2013 Jun;27(6):2220-32. doi: 10.1096/fj.12-225615. Epub 2013 Feb 13.

5.

Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.

Wu B, Mottola G, Chatterjee A, Lance KD, Chen M, Siguenza IO, Desai TA, Conte MS.

J Vasc Surg. 2017 Jan;65(1):207-217.e3. doi: 10.1016/j.jvs.2016.01.030. Epub 2016 Mar 29.

6.

Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.

Akagi D, Chen M, Toy R, Chatterjee A, Conte MS.

FASEB J. 2015 Jun;29(6):2504-13. doi: 10.1096/fj.14-265363. Epub 2015 Mar 16.

7.

Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.

Kato Y, Yokoyama U, Yanai C, Ishige R, Kurotaki D, Umemura M, Fujita T, Kubota T, Okumura S, Sata M, Tamura T, Ishikawa Y.

Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2617-25. doi: 10.1161/ATVBAHA.115.306534. Epub 2015 Oct 1.

PMID:
26427796
8.

Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.

Ashino T, Yamamoto M, Yoshida T, Numazawa S.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):760-8. doi: 10.1161/ATVBAHA.112.300614. Epub 2013 Feb 14.

PMID:
23413426
9.

IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury.

Kohno T, Urao N, Ashino T, Sudhahar V, Inomata H, Yamaoka-Tojo M, McKinney RD, Fukai T, Ushio-Fukai M.

Am J Physiol Cell Physiol. 2013 Sep 15;305(6):C591-600. doi: 10.1152/ajpcell.00011.2013. Epub 2013 May 8.

10.

Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways.

Sun JY, Li C, Shen ZX, Zhang WC, Ai TJ, Du LJ, Zhang YY, Yao GF, Liu Y, Sun S, Naray-Fejes-Toth A, Fejes-Toth G, Peng Y, Chen M, Liu X, Tao J, Zhou B, Yu Y, Guo F, Du J, Duan SZ.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):874-85. doi: 10.1161/ATVBAHA.115.307031. Epub 2016 Mar 10.

PMID:
26966277
11.

MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.

Schlosser A, Pilecki B, Hemstra LE, Kejling K, Kristmannsdottir GB, Wulf-Johansson H, Moeller JB, Füchtbauer EM, Nielsen O, Kirketerp-Møller K, Dubey LK, Hansen PB, Stubbe J, Wrede C, Hegermann J, Ochs M, Rathkolb B, Schrewe A, Bekeredjian R, Wolf E, Gailus-Durner V, Fuchs H, Hrabě de Angelis M, Lindholt JS, Holmskov U, Sorensen GL.

Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):122-33. doi: 10.1161/ATVBAHA.115.306672. Epub 2015 Nov 12.

PMID:
26564819
12.

Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.

Daniel JM, Prock A, Dutzmann J, Sonnenschein K, Thum T, Bauersachs J, Sedding DG.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):317-27. doi: 10.1161/ATVBAHA.115.305974. Epub 2015 Dec 10.

PMID:
26663397
13.

Leptin Induces Sca-1+ Progenitor Cell Migration Enhancing Neointimal Lesions in Vessel-Injury Mouse Models.

Xie Y, Potter CMF, Le Bras A, Nowak WN, Gu W, Bhaloo SI, Zhang Z, Hu Y, Zhang L, Xu Q.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2114-2127. doi: 10.1161/ATVBAHA.117.309852. Epub 2017 Sep 21.

14.

PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.

Zhang LL, Gao CY, Fang CQ, Wang YJ, Gao D, Yao GE, Xiang J, Wang JZ, Li JC.

Cardiovasc Res. 2011 Dec 1;92(3):484-93. doi: 10.1093/cvr/cvr238. Epub 2011 Aug 31.

PMID:
21880694
15.

Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.

Daniel JM, Dutzmann J, Bielenberg W, Widmer-Teske R, Gündüz D, Hamm CW, Sedding DG.

Basic Res Cardiol. 2012 May;107(3):261. doi: 10.1007/s00395-012-0261-9. Epub 2012 Mar 15.

16.

Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.

Zhou LJ, Chen XY, Liu SP, Zhang LL, Xu YN, Mu PW, Geng DF, Tan Z.

J Am Heart Assoc. 2017 Jul 27;6(8). pii: e005754. doi: 10.1161/JAHA.117.005754.

17.

C1q/TNF-related protein 1 prevents neointimal formation after arterial injury.

Kanemura N, Shibata R, Ohashi K, Ogawa H, Hiramatsu-Ito M, Enomoto T, Yuasa D, Ito M, Hayakawa S, Otaka N, Murohara T, Ouchi N.

Atherosclerosis. 2017 Feb;257:138-145. doi: 10.1016/j.atherosclerosis.2017.01.014. Epub 2017 Jan 16.

PMID:
28131048
18.

Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.

Lavin B, Gómez M, Pello OM, Castejon B, Piedras MJ, Saura M, Zaragoza C.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1739-46. doi: 10.1161/ATVBAHA.114.303866. Epub 2014 Jun 12.

PMID:
24925976
19.

Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor.

Zhang J, Zou F, Tang J, Zhang Q, Gong Y, Wang Q, Shen Y, Xiong L, Breyer RM, Lazarus M, Funk CD, Yu Y.

Circ Res. 2013 Jul 5;113(2):104-14. doi: 10.1161/CIRCRESAHA.113.301033. Epub 2013 Apr 17.

20.

miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.

Yang F, Chen Q, He S, Yang M, Maguire EM, An W, Afzal TA, Luong LA, Zhang L, Xiao Q.

Circulation. 2018 Apr 24;137(17):1824-1841. doi: 10.1161/CIRCULATIONAHA.117.027799. Epub 2017 Dec 15.

Supplemental Content

Support Center